| Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. | |
| | |
MedLine Citation:
|
PMID: 11979337 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Direct hemoperfusion (DHP) with an adsorbent column using polymyxin B-immobilized fiber (PMX-F) has been shown to improve the state of shock in patients with septic shock. However, no evidence has been presented for a direct link between endotoxin removal by DHP with PMX-F and improvement in septic shock. We retrospectively analyzed clinical profiles of 24 patients with septic shock (16 patients, gram-negative; 8 patients, non-gram-negative septic shock) who underwent DHP with PMX-F. Patients with gram-negative septic shock were characterized by hyperdynamic circulation. DHP with PMX-F reduced blood endotoxin concentrations and ameliorated shock, with an improvement in hyperdynamic circulation in patients with gram-negative septic shock. Mean arterial pressure also was elevated after therapy in patients with non-gram-negative septic shock, but systemic hemodynamics were unaffected. Regardless of the causative microorganism, patients with endotoxemia (blood endotoxin level > 10 pg/mL) showed hyperdynamic shock, and DHP with PMX-F reduced blood endotoxin levels and ameliorated hyperdynamic circulation, whereas patients without endotoxemia showed features of shock without hyperdynamic circulation, and DHP with PMX-F ameliorated shock without affecting cardiac performance. In patients with gram-negative septic shock, blood endotoxin concentration correlated positively with cardiac output and negatively with systemic vascular resistance before DHP therapy. Reduction in blood endotoxin concentration by DHP therapy positively correlated with the reduction in cardiac output. Our findings indicate that the improvement in hyperdynamic circulation was related directly to endotoxin removal by the PMX-F column, and endotoxin has an important role in the development of hyperdynamic circulation in patients with gram-negative septic shock. |
| | |
Authors:
|
Kohei Uriu; Akihiko Osajima; Kinya Hiroshige; Hiroyuki Watanabe; Keiji Aibara; Yoshifumi Inada; Kayoko Segawa; Hiroshi Anai; Ichiro Takagi; Aki Ito; Masayuki Kamochi; Kazo Kaizu |
Related Documents
:
|
7244947 - Fatal respiratory distress in burned patients. 7743427 - Early administration of enteral nutrients in critically ill patients. 15538587 - A standardised protocol for the acute management of corrosive ingestion in children. 18272107 - Should etomidate be used for rapid-sequence intubation induction in critically ill sept... 12576437 - Phase ii clinical trial of intralesional administration of the oncolytic adenovirus ony... 22442747 - Acquired double pylorus, due to penetrating gastric ulcer, presenting with melena. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American journal of kidney diseases : the official journal of the National Kidney Foundation Volume: 39 ISSN: 1523-6838 ISO Abbreviation: Am. J. Kidney Dis. Publication Date: 2002 May |
Date Detail:
|
Created Date: 2002-04-29 Completed Date: 2002-06-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8110075 Medline TA: Am J Kidney Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 937-47 Citation Subset: IM |
Copyright Information:
|
Copyright 2002 by the National Kidney Foundation, Inc. |
Affiliation:
|
Kidney Center, First Department of Internal Medicine, University of Occupational and Environmental Health School of Medicine, Kitakyusyu, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adsorption Bacteremia / therapy Endotoxins / blood*, pharmacokinetics Gram-Negative Bacterial Infections / therapy Gram-Positive Bacterial Infections / therapy Hemoperfusion / instrumentation*, methods* Humans Middle Aged Peripheral Vascular Diseases / therapy* Polymyxin B / metabolism* Retrospective Studies Shock, Septic / therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Endotoxins; 1404-26-8/Polymyxin B |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hospital-acquired renal insufficiency.
Next Document: Quantitative analyses of osteopontin mRNA expression in human proximal tubules isolated from renal b...